Skip to main content
Terug
Watch Compare

Scilex Holding Co

Datakwaliteit: 100%
Ook genoteerd als SCLXW NASDAQ
SCLX
NASDAQ Manufacturing Chemicals
€ 6,80
▼ € 0,21 (-3,00%)
Marktkapitalisatie: 49,23 M
Prijs
€ 7,00
Marktkapitalisatie
49,23 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Generating 23,82 M in free cash flow
Capital efficient — spends only 0,00% of revenue on capex

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)21,07%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net Margin-828,56%
Op. Margin-652,37%

Veiligheid

Debt / Equity
N/A
Current Ratio0,05
Interest Coverage-31,93

Waardering

PE (TTM|NTM|2027)
-0,15 | 9,32 | 9,59
Boven sectorgemiddelde (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E -0,2 -1,5
P/B — 1,6
ROE % — -54,4
Net Margin % -828,6 -41,5
Rev Growth 5Y % — 1,9
D/E — 0,3

Koersdoel Analisten

1 analist
Geen analistendekking beschikbaar

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 € 0,73
€ 0,73 – € 0,73
 188,97 M 1
FY2026 -€ 0,89
-€ 0,89 – -€ 0,89
 66,00 M 1

Winstverassingen

Laatste 5 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,47 -€ 1,17 -149,3%
Q32025 -€ 0,41 -€ 21,29 -5093,4%
Q22025 -€ 0,91 -€ 7,42 -715,4%
Q12025 -€ 0,01 -€ 1,73 -17202,0%
Q42024 -€ 3,15 -€ 2,37 +24,9%

ETFs Holding This Stock

STXK logo STXK Strive Small-Cap ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 21,07% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 40,36 M Net Income (TTM) -334,41 M
ROE N/A ROA -185,97%
Gross Margin N/A Operating Margin -652,37%
Net Margin -828,56% Free Cash Flow (TTM) 23,82 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,05
Interest Coverage -31,93 Asset Turnover 0,22
Working Capital -342,46 M Tangible Book Value -220,84 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,15 Forward P/E 9,32
P/B Ratio N/A P/S Ratio 1,22
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 0,26 Fwd Earnings Yield 10,73%
FCF Yield 48,39%
Market Cap 49,23 M Enterprise Value 48,35 M
Per Share
EPS (Diluted TTM) -31,93 Revenue / Share 5,74
FCF / Share 3,39 OCF / Share 3,39
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,00% FCF Conversion -7,12%
SBC-Adj. FCF 10,26 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2021 FY2022 FY2020
Revenue 56,59 M 46,74 M — 38,03 M —
Net Income -72,81 M -114,33 M 783.438,0 -23,36 M -6.276,0
EPS (Diluted) -0,61 -1,28 0,05 -0,17 —
Gross Profit — — — — —
Operating Income -83,40 M -105,43 M -1,01 M -50,63 M —
EBITDA — — — — —
R&D Expenses 9,64 M 12,75 M — 9,05 M —
SG&A Expenses 119,02 M 119,64 M — 64,90 M —
D&A 4,05 M 4,15 M — 3,96 M —
Interest Expense 1,96 M 1,07 M 1.826,0 9,60 M 50.000,0
Income Tax -1.000,0 13.000,0 — 4.000,0 —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2021 FY2022 FY2020
Total Assets 92,95 M 101,31 M 139,92 M 86,53 M 199.484,0
Total Liabilities 285,59 M 274,25 M 9,24 M 50,29 M —
Shareholders' Equity -192,64 M -172,94 M -8,70 M 36,24 M 18.724,0
Total Debt — — — 0,0 —
Cash & Equivalents 3,27 M 3,92 M 507.921,0 2,18 M 30.511,0
Current Assets 41,55 M 46,78 M 512.457,0 29,61 M —
Current Liabilities 259,64 M 250,38 M 208.704,0 44,84 M 180.760,0